Cargando…
Chemotherapy regimens in rare solid tumors /
Rare tumors are an increasing problem in oncology. Aim of this book is to offer a help in spreading the knowledge of low-incidence tumors in oncology. Each chapter provides brief information about the epidemiology of and clinical aspects for every RT; and, following each chemotherapy schedule, we re...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Torino :
SEEd Srl,
2011.
|
| Edición: | First edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn773565234 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 120123s2011 it ob 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e rda |e pn |c EBLCP |d OCLCQ |d MHW |d MERUC |d E7B |d OCLCQ |d CCO |d AZK |d N$T |d OCLCF |d YDXCP |d DKDLA |d OCLCQ |d ICA |d AGLDB |d MOR |d PIFAG |d ZCU |d OCLCQ |d U3W |d STF |d WRM |d VTS |d NRAMU |d ICG |d VT2 |d OCLCQ |d TKN |d DKC |d OCLCQ |d AJS |d OCLCO |d OCLCQ |d QGK |d S2H |d OCLCO |d OCLCQ |d OCLCL | ||
| 019 | |a 871897182 |a 961490877 |a 962626707 |a 1259214688 |a 1289516968 | ||
| 020 | |a 9788897419082 |q (electronic bk.) | ||
| 020 | |a 8897419089 |q (electronic bk.) | ||
| 020 | |a 9788897419075 | ||
| 020 | |a 8897419070 | ||
| 029 | 1 | |a AU@ |b 000053011672 | |
| 029 | 1 | |a DEBBG |b BV040884251 | |
| 029 | 1 | |a DEBBG |b BV043957859 | |
| 029 | 1 | |a DEBBG |b BV044188211 | |
| 029 | 1 | |a DEBSZ |b 481268162 | |
| 029 | 1 | |a NZ1 |b 15024395 | |
| 035 | |a (OCoLC)773565234 |z (OCoLC)871897182 |z (OCoLC)961490877 |z (OCoLC)962626707 |z (OCoLC)1259214688 |z (OCoLC)1289516968 | ||
| 050 | 4 | |a RD123.5 |b .B652 2008 | |
| 050 | 4 | |a RM262 | |
| 072 | 7 | |a MED |x 085000 |2 bisacsh | |
| 082 | 0 | 4 | |a 617.4/4 |a 617.44 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Comandone, Alessandro, |e author. | |
| 240 | 1 | 0 | |a Schemi chemioterapici e tossicitá correlate |
| 245 | 1 | 0 | |a Chemotherapy regimens in rare solid tumors / |c Alessandro Comandone. |
| 250 | |a First edition. | ||
| 264 | 1 | |a Torino : |b SEEd Srl, |c 2011. | |
| 300 | |a 1 online resource (144 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |2 rda | ||
| 504 | |a Includes bibliographical references (pages 124-143). | ||
| 505 | 0 | |a Preface -- 1. Rare tumors of the thorax -- Mesothelioma -- Mesothelioma: Cisplatin + Pemetrexed -- Mesothelioma: Carboplatin + Pemetrexed -- Mesothelioma: Cisplatin + Gemcitabine -- Mesothelioma: Cisplatin + Doxorubicin -- Mesothelioma: Pemetrexed -- Mesothelioma: Pemetrexed + Gemcitabine -- Mesothelioma: Gemcitabine + Cisplatin -- Thymoma -- Thymoma: PAC -- Thymoma: PACE -- Thymoma: ADOC -- Thymoma: PE (EORTC) -- 2. Endocrine glands tumors -- Anaplastic thyroid carcinoma -- Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin -- Anaplastic thyroid carcinoma: Doxorubicin -- Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma -- Medullary thyroid carcinoma: CVD -- Medullary thyroid carcinoma: Sz/M -- Carcinoma of parathyroid -- Parathyroid carcinoma: CFuD -- Parathyroid carcinoma: Dacarbazine -- Adrenocortical carcinoma -- Adrenocortical carcinoma: Mitotane -- Adrenocortical carcinoma: EDP/M -- Adrenocortical carcinoma: EP + Mitotane -- Adrenocortical carcinoma: Sz/M -- Feocromocitoma -- Feocromocitoma: CVD -- 3. Neuroendocrine tumors -- Gastroenteropancreatic neuroendocrine tumors (GEP) -- GEP: Streptozotocin + Doxorubicin -- GEP: Streptozotocin + 5-Fluorouracil -- GEP: FDEGEP: IFN -- GEP: Octreotide LAR -- GEP: Lanreotide -- GEP: DTIC -- Poorly-differentiated neuroendocrine tumor of different sites -- Poorly-differentiated neuroendocrine tumor: PE -- Poorly-differentiated neuroendocrine tumor: CAV -- Poorly-differentiated neuroendocrine tumor: Topotecan -- Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin -- Poorly-differentiated neuroendocrine tumor: EC -- Poorly-differentiated neuroendocrine tumor: Etoposide orally -- Poorly-differentiated neuroendocrine tumor: PEC -- 4. Rare gynecological tumors -- Vulvar cancers -- Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy) -- Vulvar cancer: Cisplatin + Bleomycin -- Vulvar cancer: Cisplatin + 5-Fluorouracil -- Vulvar cancer: Cisplatin + Vinorelbine -- Uterine sarcomas -- Uterine sarcomas (Leiomyosarcoma): HD-IFO -- Uterine sarcomas (Leiomyosarcoma): Dacarbazine -- Uterine sarcomas (Leiomyosarcoma): Dacarbazine -- Uterine sarcomas (Leiomyosarcoma): Doxorubicin -- Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide -- Uterine sarcomas (Leiomyosarcoma): MAID -- Uterine sarcomas (Leiomyosarcoma): Trabectedin -- Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP -- Carcinosarcoma (mixed müllerian tumor): TAP -- Vaginal carcinoma -- Vaginal carcinoma: Cisplatin + Vinorelbine -- Vaginal carcinoma: Cisplatin + Bleomycin -- Vaginal carcinoma: BIP -- Vaginal carcinoma: BOMP -- Vaginal carcinoma: Cisplatin + 5-Fluorouracil -- Vaginal carcinoma: Cisplatin + Paclitaxel -- Vaginal carcinoma: Carboplatin + Paclitaxel -- 5. Rare tumors of male genital tract -- Testicular tumors and disgerminomas -- Testicular tumors and disgerminomas: BEP -- Testicular tumors: PVB -- 6. Sarcomas and GIST -- 7. Head and neck rare tumors -- 8. Gastrointestinal rare tumors -- 9. Raren tumors of the skin -- 10. Rare tumors of urniary tract -- References. | |
| 500 | |a Testicular tumors: VeIP (rescue regimen). | ||
| 520 | |a Rare tumors are an increasing problem in oncology. Aim of this book is to offer a help in spreading the knowledge of low-incidence tumors in oncology. Each chapter provides brief information about the epidemiology of and clinical aspects for every RT; and, following each chemotherapy schedule, we report a short description of the hematologic toxicities related to the treatment. | ||
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Chemotherapy. | |
| 650 | 0 | |a Tumors. | |
| 650 | 2 | |a Drug Therapy | |
| 650 | 2 | |a Neoplasms | |
| 650 | 6 | |a Chimiothérapie. | |
| 650 | 6 | |a Tumeurs. | |
| 650 | 7 | |a MEDICAL |x Surgery |x General. |2 bisacsh | |
| 650 | 7 | |a Chemotherapy |2 fast | |
| 650 | 7 | |a Tumors |2 fast | |
| 758 | |i has work: |a Chemotherapy Regimens in Rare Solid Tumors (Online) (Text) |1 https://id.oclc.org/worldcat/entity/E39PCY89QW78mwkx86rpK87k8P |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Comandone, Alessandro. |t Chemotherapy Regimens in Rare Solid Tumors. |d Torino : SEEd Srl, ©2011 |z 9788897419075 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=837840 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL837840 | ||
| 938 | |a ebrary |b EBRY |n ebr10572354 | ||
| 938 | |a EBSCOhost |b EBSC |n 770597 | ||
| 938 | |a YBP Library Services |b YANK |n 7360397 | ||
| 994 | |a 92 |b IZTAP | ||